RGLGX | RWIFX | RGLGX / RWIFX | |
Total Expense Ratio | 0.45 | 0.46 | 98% |
Annual Report Gross Expense Ratio | 0.45 | 0.46 | 98% |
Fund Existence | 6 years | 23 years | - |
Gain YTD | 15.740 | 15.690 | 100% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 250 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 18B | 137B | 13% |
Annual Yield % from dividends | 1.12 | 1.72 | 65% |
Returns for 1 year | 16.13 | 11.77 | 137% |
Returns for 3 years | 46.15 | 42.33 | 109% |
Returns for 5 years | 62.98 | 49.16 | 128% |
Returns for 10 years | N/A | 66.20 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IDNA | 22.88 | 0.48 | +2.14% |
iShares Genomics Immnlgy & Hlthcr ETF | |||
CAOS | 89.24 | 0.13 | +0.15% |
Alpha Architect Tail Risk ETF | |||
VNLA | 49.17 | 0.01 | +0.02% |
Janus Henderson Short Duration Inc ETF | |||
ITDH | 35.74 | N/A | -0.01% |
iShares LifePath Target Date 2060 ETF | |||
RND | 28.10 | -0.06 | -0.20% |
First Trust Bloomberg R&D Leaders ETF |